| The use of therapeutic peptides to target and to kill cancer cells R J Boohaker, M W Lee, P Vishnubhotla, J LM Perez, A R Khaled Current medicinal chemistry 19 (22), 3794-3804, 2012 | 380 | 2012 |
| Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer L Ai, Q Tao, S Zhong, CR Fields, WJ Kim, MW Lee, Y Cui, KD Brown, ... Carcinogenesis 27 (7), 1341-1348, 2006 | 228 | 2006 |
| Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells H Yamaguchi, SR Paranawithana, MW Lee, Z Huang, KN Bhalla, ... Cancer research 62 (2), 466-471, 2002 | 137 | 2002 |
| Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer H Heers, J Stanislaw, J Harrelson, MW Lee European Journal of Pharmacology 835, 61-74, 2018 | 95 | 2018 |
| Arsenic trioxide (As2O3) induces apoptosis through activation of Bax in hematopoietic cells Y Zheng, H Yamaguchi, C Tian, MW Lee, H Tang, HG Wang, Q Chen Oncogene 24 (20), 3339-3347, 2005 | 90 | 2005 |
| Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies E Melamed, MW Lee Frontiers in Immunology 10, 2019 | 78 | 2019 |
| Rational development of a cytotoxic peptide to trigger cell death RJ Boohaker, G Zhang, MW Lee, KN Nemec, S Santra, JM Perez, ... Molecular pharmaceutics 9 (7), 2080-2093, 2012 | 49 | 2012 |
| The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption. MW Lee, R Bassiouni, NA Sparrow, A Iketani, RJ Boohaker, C Moskowitz, ... Cell Death and Disease 5 (e1249), 1-11, 2014 | 46 | 2014 |
| Caspase-3-mediated cleavage of Rad9 during apoptosis MW Lee, I Hirai, HG Wang Oncogene 22 (41), 6340-6346, 2003 | 46 | 2003 |
| Expanding the view of breast cancer metabolism: Promising molecular targets and therapeutic opportunities JP Harrelson, MW Lee Pharmacology and Therapeutics, 2016 | 42 | 2016 |
| Deoxycytidine kinase regulates the G2/M checkpoint through interaction with cyclin-dependent kinase 1 in response to DNA damage C Yang, M Lee, J Hao, X Cui, X Guo, C Smal, F Bontemps, S Ma, X Liu, ... Nucleic acids research 40 (19), 9621-9632, 2012 | 38 | 2012 |
| Current methods in translational cancer research MW Lee, M Miljanic, T Triplett, C Ramirez, KL Aung, SG Eckhardt, ... Cancer and Metastasis Reviews, 2020 | 34 | 2020 |
| How to assess kidney function in oncology patients J Malyszko, MW Lee, G Capasso, P Kulicki, J Matuszkiewicz-Rowinska, ... Kidney International, 2020 | 30 | 2020 |
| Design of a foundational sciences curriculum: Applying the ICAP framework to pharmacology education in integrated medical curricula KM Quesnelle, NT Zaveri, SD Schneid, JB Blumer, JL Szarek, ... Pharmacology Research and Perspectives, 2021 | 27 | 2021 |
| Medical Care in a Free Clinic: A Comprehensive Evaluation of Patient Experience, Incentives, and Barriers to Optimal Medical Care with Consideration of a Facility Fee A Birs, X Liu, B Nash, S Sullivan, S Garris, M Hardy, M Lee, ... Cureus 8 (2), 2016 | 26 | 2016 |
| Integration of Microbiology, Pharmacology, Immunology, and Infectious Disease Using Active Teaching and Self-Directed Learning N Steinel, GC Palmer, E Nowicki, E Lee, E Nelson, M Whiteley, MW Lee Medical Science Educator, 2019 | 22 | 2019 |
| New insights into the synergism of nucleoside analogs with radiotherapy MW Lee, WB Parker, B Xu Radiation Oncology 8 (1), 223-232, 2013 | 20 | 2013 |
| The renal adverse effects of cancer immunotherapy NC Steinel, EM Lee, D Viggiano, A Capasso, MW Lee Journal of Nephrology 33 (3), 467-481, 2020 | 18 | 2020 |
| Development of Statistical Models to Predict Medical Student Performance on the USMLE Step 1 as a Catalyst for Deployment of Student Services MW Lee, TR Johnson, J Kibble Medical Science Educator, 2017 | 16 | 2017 |
| Words of advice: preparing to teach D Silverthorn, MW Lee, C SB, EA Nelson, AD Bergemann FEBS Journal, 2020 | 14 | 2020 |
